All these data suggest that ALDH3A1 promotes glycolysis and inhibits OXPHOS by activating the HIF-1α/LDHA pathway in NSCLC, which can be suppressed by β-elemene. Here, ALDH3A1 is linked to non-small cell lung carcinoma.